Eli Lilly and Company today announced results from the Phase 3 LIBRETTO-432 clinical trial of Retevmo (selpercatinib) as adjuvant therapy versus placebo in patients with early-stage (IB-IIIA) ...
Pfizer Inc. today announced detailed results from the pivotal Phase 3 TALAPRO-3 study of TALZENNA® (talazoparib), an oral poly ADP-ribose polymerase (PARP) inhibitor, in combination with XTANDI® ...
Philstar Life on MSN
These Filipinos got addicted to smoking, vaping as early as 12. Here's how they overcame it
Kyle Esposado first picked up a vape as early as 12 years old, having been influenced by none other than his own family. “I ...
A 24-hour stomach bug typically involves symptoms such as vomiting, diarrhea, nausea, and stomach pain. Stomach bugs are a nonmedical name for viral infections. These infections are often ...
"Early molecular testing is critically important now in these mCSPC patients,” said TALAPRO-3 lead investigator Neeraj Agarwal, MD. Adding talazoparib to enzalutamide reduced the risk of radiographic ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results